BioCardia Inc.

BCDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.08

-$0.09 (-7.69%)

At close: Sep 21, 2026, 4:00 PM ET

$1.03

-$0.05 (-4.63%)

After-hours: Sep 21, 2026, 7:55 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-7.69%

(1D)

Rating

Updated: Aug 26, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $16.08M

1D Range

1.07 1.19

52W Range

0.75 1.80

Valuation (TTM)

PE -1.42

PB 5.95

EV/EBITDA -1.77

Valuation (NTM)

Forward PE N/A

Forward PEG 0.08

Price Target $25

Cash Flow

FCF Yield -47.1%

SBC Adj. FCF Yield -49.5%

SBC Impact -5.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -150.0% | -77.0%

Dil EPS 3Y | 5Y 80.4% | 46.1%

FCF 3Y | 5Y -3.0% | 10.8%

Returns

ROA -154.3%

ROE -569.4%

ROIC -246.9%

Financial Health

Net Cash

$4.12M

Current Ratio 2.09

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respir...

Sector Healthcare

Industry Biotechnology

Employees 17

IPO Date Nov 12, 1996

Website www.biocardia.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$25

Upside

+2214.81%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞